These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3760580

  • 41. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 42. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S, Hombach A, Köhler S, Schlebusch H, Wallwiener D, Abken H, Wagner U.
    Cancer Res; 2003 Jun 15; 63(12):3234-40. PubMed ID: 12810653
    [Abstract] [Full Text] [Related]

  • 43. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
    Klehr M, Koehl U, Mühlenhoff M, Tawadros S, Fischer T, Schomäcker K, Heuckmann JM, Bochennek K, Jensen M.
    J Immunother; 2009 Jun 15; 32(5):442-51. PubMed ID: 19609236
    [Abstract] [Full Text] [Related]

  • 44. Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.
    Steplewski Z, Spira G, Blaszczyk M, Lubeck MD, Radbruch A, Illges H, Herlyn D, Rajewsky K, Scharff M.
    Proc Natl Acad Sci U S A; 1985 Dec 15; 82(24):8653-7. PubMed ID: 2934735
    [Abstract] [Full Text] [Related]

  • 45. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody.
    Hashimoto Y, Sugawara M, Masuko T, Hojo H.
    Cancer Res; 1983 Nov 15; 43(11):5328-34. PubMed ID: 6616468
    [Abstract] [Full Text] [Related]

  • 46. Monoclonal antibody therapy of lymphoid malignancy.
    Lowder JN, Meeker TC, Levy R.
    Cancer Surv; 1985 Nov 15; 4(2):359-75. PubMed ID: 3842318
    [Abstract] [Full Text] [Related]

  • 47. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T, Kuroki M, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S, Matsuoka Y.
    Anticancer Res; 1998 Nov 15; 18(1A):17-24. PubMed ID: 9568050
    [Abstract] [Full Text] [Related]

  • 48. CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells.
    Wulf GG, Boehnke A, Chapuy B, Glass B, Hemmerlein B, Schroers R, Brenner MK, Truemper L.
    Haematologica; 2006 Jul 15; 91(7):886-94. PubMed ID: 16818275
    [Abstract] [Full Text] [Related]

  • 49. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 15; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 50. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
    Sundstedt A, Celander M, Hedlund G.
    Int Immunopharmacol; 2008 Mar 15; 8(3):442-52. PubMed ID: 18279798
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T, Seto M, Hara T.
    Gan To Kagaku Ryoho; 1983 Aug 15; 10(8):1894-1900. PubMed ID: 6882010
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide.
    Campbell MJ, Esserman L, Levy R.
    J Immunol; 1988 Nov 01; 141(9):3227-33. PubMed ID: 3049819
    [Abstract] [Full Text] [Related]

  • 57. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.
    Greiner JW, Guadagni F, Hand PH, Pestka S, Noguchi P, Fisher PB, Schlom J.
    Cancer Treat Res; 1990 Nov 01; 51():413-32. PubMed ID: 1977458
    [Abstract] [Full Text] [Related]

  • 58. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
    Lanier LL, Babcock GF, Lynes MA, Haughton G.
    J Natl Cancer Inst; 1979 Dec 01; 63(6):1417-22. PubMed ID: 316036
    [No Abstract] [Full Text] [Related]

  • 59. Isotype switch variant anti-idiotype monoclonal antibodies: comparative radiolabeling and in vitro binding.
    Wahl RL, Wissing JR, Kaminski MS.
    J Nucl Med; 1989 Feb 01; 30(2):227-32. PubMed ID: 2738651
    [Abstract] [Full Text] [Related]

  • 60. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses.
    Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R.
    Blood; 1987 Jan 01; 69(1):199-210. PubMed ID: 2431729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.